Admission Date:  [**2169-1-5**]              Discharge Date:   [**2169-1-11**]  Date of Birth:  [**2085-6-22**]             Sex:   F  Service: MEDICINE  Allergies: Penicillins  Attending:[**First Name3 (LF) 1253**] Chief Complaint: Sepsis  Major Surgical or Invasive Procedure: ERCP [**2169-1-6**] PICC line placement [**2169-1-9**]   History of Present Illness: 83 year old female with a history of biliary obstruction due to tumor with metal stents presenting to an OSH on [**1-3**] with an episode of weakness/incontinence found to have polymicrobial bacteremia/sepsis.
The patient was treated for a UTI on [**12-21**] with Macrobid.
She was treated initially with levofloxacin, but changed to Imipenim and gentamicin with improvement in her clinical status.
The patient was transferred to [**Hospital1 18**] on [**2169-1-5**] for ERCP evaluation of her metal biliary stents given CT findings.
Currently, she complains of irritation by the Foley, but denies headache, blurry vision, dry mouth, thirst, difficulty/pain with swallowing, chest pain, shortness of breath, palpitations, nausea, heartburn, vomiting, abdominal pain, diarrhea, constipation (though notes no BM in 1 week), new weakness, numbness or tingling.
Past Medical History: -Biliary obstruction/malignant stricture s/p ERCP X 2 and 2 metal stents--last placed in [**9-12**].
-Diabetes mellitus, type 2 -Hypertension -Coronary artery disease -Parkinson's disease -diastolic CHF -Vaginal Carcinoma -s/p Cholecystectomy -Urosepsis d/t E. coli and Proteus -Bacteremia due to VRE in [**9-12**] treated with 2 week course of Linezolid -Bacteremia due to E. coli in [**9-12**] treated with 2 week course of Ceftriaxone.
-Atrial fibrillation -Hyperlipidemia  Social History: lives with husband in [**Name (NI) 3320**] no children.
Pertinent Results: Admission Labs: [**2169-1-5**] 06:04PM   WBC-25.6*# RBC-4.26 HGB-11.5* HCT-35.4* MCV-83 MCH-27.1 MCHC-32.6 RDW-17.7* [**2169-1-5**] 06:04PM   NEUTS-91.3* LYMPHS-6.0* MONOS-2.5 EOS-0 BASOS-0.1 [**2169-1-5**] 06:04PM   PLT COUNT-120*# [**2169-1-5**] 06:04PM   PT-14.0* PTT-20.6* INR(PT)-1.2* [**2169-1-5**] 06:04PM   ALT(SGPT)-8 AST(SGOT)-27 LD(LDH)-152 ALK PHOS-139* TOT BILI-1.1 [**2169-1-5**] 06:04PM   GLUCOSE-111* UREA N-36* CREAT-0.8 SODIUM-142 POTASSIUM-4.4 CHLORIDE-110* TOTAL CO2-25 ANION GAP-11 [**2169-1-5**] 06:04PM   ALBUMIN-2.8* CALCIUM-9.8 PHOSPHATE-2.7 MAGNESIUM-1.9  OSH ([**Date range (1) 69929**]-[**Date range (1) **]) Labs WBC 26.6(87P,8B)->33.7(84P,6B)->30.1(87P,7B)->25.2 HCT 37.6->28.7->30.5->31.8 Plt 245->201->109->93 PT/INR ([**1-5**]) 11.4/1.1 Cr 1.44->1.32->1.08->0.75 Alb 1.9 TB 1.9->1.5->1.2 AP 198->134->128 AST 46->35->30 ALT <5->24->7 TNI 0.12 ([**2169-1-2**]) BNP 733 ([**1-3**])->1508 ([**1-4**]) UA: neg LE, neg nit, 1+ gluc, trace acetone, 1.015  OSH Micro: [**2169-1-2**]: Blood culture-E. coli (Amp R, Cipro R, [**Last Name (un) **] Augmentin, Aztreonam, Cefazolin, Cefoxitin, Ceftriaxone, fent, imipenem, zosyn) [**2169-1-2**]: Urine culture-negative [**2169-1-2**]: Blood cluture: K. pneumonia, other GNR [**2169-1-4**]: Blood culture: GNR, GPC [**2169-1-4**]: Blood culture: GPC [**2169-1-4**]: Sputum culture: Yeast  OSH studies: 1.
CT abd/pelvis ([**1-3**]): double biliary stent catheter in place with evidence of continued biliary obstruction throught the liver--not improved.
Liver shows areas of decreased enhancement in posterior right lobe and in the anterior left lobe with no definite mass effect seen suspicious for possibility of infections at that site.
Procedures: Multiple stone fragments and sludge were extracted successfully using a 11 mm balloon.
The nasogastric tube has been removed.
The largest measures approximately 2 cm and may be amenable to percutaneous sampling if desired, but is not likely amenable to catheter drainage at its present size.
9-mm pancreatic hypodensity, not previously visualized.
[**2169-1-10**] CPK 10  AST 26  ALT 6  AlkPh 135  Tb 1.4   Brief Hospital Course: 83 year old female with history of biliary obstruction, polymicrobial bacteremia from cholangitis presented with biliary sepsis.
On transfer to the floor from [**Hospital Unit Name 153**], she was transitioned to linezolid and gentamicin alone.
ID was consulted, and antibiotics were changed from Linezolid and Gent to Ceftriaxone and Daptomycin on [**1-10**] due to the duration of treatment that will be required.
# Cholangiocarcinoma: Discussion with family to clarify goals of care revealed that patient is not planning on surgery or chemo/XRT given extremely poor prognosis of cancer.
CHADS score is 4, and she was placed on Lovenox with transition to coumadin.
- resumed Lovenox [**2169-1-9**] s/p PICC placement for coumadin bridge - INR 1.9 at time of discharge - Coumadin dosing:  5 mg po q 1600 since [**2169-1-9**].
Please follow INR and titrate coumadin dosing as appropriate.
The patient was started on a heparin gtt with a goal PTT of 50-70, and then transitioned to Lovenox/coumadin.
- on lovenox/coumadin .
Has LE edema and is on chronic Lasix at home.
ECG here with new TWI V1-V4 and maintainance of new axis since [**1-2**]--cycled enzymes; Trp 0.05 but CK-Mb remained negative.
She was continued on aspirin and a statin.
- Currently appears euvolemic and BUN/Cr stable - restarted Lasix [**1-10**] .
# Concern for aspiration: There was concern that the patient aspirated her pm meds so her meds were changed to IV and speech and swallow c/s was requested.
PO intake of nectar thick liquids and ground solids.
# Parkinson's Disease: She was continued on Sinemet.
Medications on Admission: Medications at home: simvastatin 10 mg daily, lasix 40 mg daily, omeprazole 40 mg daily, albuterol 2 puffs/4x day, singulair 10 mg daily, MVI, prazosin 2 mg [**Hospital1 **], mirapex 0.375 mg tid, carbidopa/levodopa 25/100 mg three times per day  Medications at transfer from rehab: Albuterol neb q4h, SSI, Lovenox, Protonix 40 mg IV daily, simvastatin 10 mg qhs, singulair 10 mg daily, MVI, Aspirin 81 mg daily, gentamicin 120 mg IV daily since [**1-3**], nystatin, imipenim/cilastin 250 mg IV q6h, pramipexole 0.375 mg tid, sinemet 25/100 mg three times/day, digoxin 0.25 mg IV q4h X 4 doses (received X 4), vancomycin 1 gm IV q24h, digoxin 0.125 mg po daily, propafenone.
Diltiazem gtt stopped [**2169-1-5**] at 12 am.
Carbidopa-Levodopa 25-100 mg Tablet Sig: One (1) Tablet PO TID (3 times a day).
Simvastatin 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for Nebulization Sig: One (1)  Inhalation Q6H (every 6 hours) as needed.
Montelukast 10 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily).
Ipratropium Bromide 0.02 % Solution Sig: One (1) nebs Inhalation Q6H (every 6 hours) as needed for wheezing.
Digoxin 125 mcg Tablet Sig: One (1) Tablet PO EVERY OTHER DAY (Every Other Day).
Metoprolol Tartrate 25 mg Tablet Sig: 0.5 Tablet PO BID (2 times a day).
Enoxaparin 80 mg/0.8 mL Syringe Sig: One (1) inj Subcutaneous Q12H (every 12 hours) for until INR >2 days.
Warfarin 5 mg Tablet Sig: One (1) Tablet PO Once Daily at 4 PM: please follow INR and titrate dose accordingly.
Furosemide 40 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Heparin Flush (10 units/ml) 2 mL IV PRN line flush PICC, heparin dependent: Flush with 10mL Normal Saline followed by Heparin as above daily and PRN per lumen.
CeftriaXONE 1 g IV Q24H Start: In am 15.
Daptomycin 500 mg Recon Soln Sig: One (1) Recon Soln Intravenous Q24H (every 24 hours).
Insulin Regular Human 100 unit/mL Solution Sig: One (1) per sliding scale Injection ASDIR (AS DIRECTED).
Discharge Disposition: Extended Care  Facility: [**Hospital 169**] Center  Discharge Diagnosis: # Biliary sepsis # Biliary obstruction # Liver abscesses # Cholangiocarcinoma # Paroxysmal atrial fibrillation # Left lower extremity DVT # Chronic diastolic CHF # Parkinson's disease   Discharge Condition: stable   Discharge Instructions: Please seek medical attention if you develop fevers, chills, changes in mental status, abdominal pain, or any other concerns.
Followup Instructions: Please continue to take antibiotics as prescribed.
